Concepedia
Statistics
Publications
12
Citations
390
H-Index
11
Active since
1993
Affiliations
Taiho Pharmaceutical (Japan)(Current)
Translational Research in Oncology
Hiroshima University
Kagoshima University
Japanese Foundation For Cancer Research
Hiroaki Tsujimoto is an author at Taiho Pharmaceutical (Japan) specializing in oncology, pharmacology, and medicine.
Publications per year
1993–2012
Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells
Makoto Inaba, Junko Mitsuhashi, Hiroko Sawada et al. · Japanese Journal of Cancer Research · 1996 · 68 citations · Full text
Medicine, Oncology, Pharmacology +17
Targeted Deletion of Both Thymidine Phosphorylase and Uridine Phosphorylase and Consequent Disorders in Mice
Misako Haraguchi, Hiroaki Tsujimoto, Masakazu Fukushima et al. · Molecular and Cellular Biology · 2002 · 61 citations · Full text
Life Sciences, Biochemistry, Genetics +17
Aberrant Methylation of <b> <i>DPYD</i> </b> Promoter, <b> <i>DPYD</i> </b> Expression, and Cellular Sensitivity to 5-Fluorouracil in Cancer Cells
Takuya Noguchi, Keiji Tanimoto, Tatsushi Shimokuni et al. · Clinical Cancer Research · 2004 · 58 citations
Life Sciences, Molecular Biology, Oncology +16
New Ring C-<i>s</i><i>eco</i> Limonoids from Brazilian <i>Melia </i><i>a</i><i>zedarach </i>and Their Cytotoxic Activity
Honglei Zhou, Atsuko Hamazaki, José D. Fontana et al. · Journal of Natural Products · 2004 · 43 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
Folylpolyglutamate synthase and gamma-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity.
Etsuko Sakamoto, Sayaka Tsukioka, Shinji Oie et al. · PubMed · 2008 · 29 citations
Medicine, Oncology, Pharmacology +11
1–5 of 12